Cargando…

Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+ Cancer Stem Cells

HER2 is an oncogenic tumor-associated antigen overexpressed in 20-25% of breast cancers, which is associated with increased invasion, metastasis of the disease and resistance to therapy. Recent studies have further shown that HER2 can increase the population of breast cancer stem cells (BCSCs). Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Su He, Lu, Lin, Fan, Yongyi, Wicha, Max S., Cao, Zhengyi, Chang, Alfred E., Xia, Jian-chuan, Baker Jr., James R., Li, Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2013
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879588/ https://www.ncbi.nlm.nih.gov/pubmed/24391448 http://dx.doi.org/10.7150/ijbs.6309

Ejemplares similares

Promise of cancer stem cell vaccine
por: Zhou, Li, et al.
Publicado: (2015)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012)

Similarity on neural stem cells and brain tumor stem cells in transgenic brain tumor mouse models
por: Qiao, Guanqun, et al.
Publicado: (2013)

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Overexpression of BID in thyroids of transgenic mice increases sensitivity to iodine-induced autoimmune thyroiditis
por: Wang, Su He, et al.
Publicado: (2014)

Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy
por: Lin, Ming, et al.
Publicado: (2017)

Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells
por: Lu, Lin, et al.
Publicado: (2015)

Targeting cancer stem cells via integrin β4
por: Dobson, Hannah E., et al.
Publicado: (2021)

Effective Treatment of Skin Wounds Co-Infected with Multidrug-Resistant Bacteria with a Novel Nanoemulsion
por: Chen, Jesse, et al.
Publicado: (2022)

Cancer stem cell heterogeneity in hereditary breast cancer
por: Wicha, Max S
Publicado: (2008)

Modified Nanoemulsions with Iron Oxide for Magnetic Resonance Imaging
por: Fan, Yongyi, et al.
Publicado: (2016)

Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis
por: Wicha, Max S
Publicado: (2006)

Metabolic plasticity of cancer stem cells
por: Luo, Ming, et al.
Publicado: (2015)

Migratory gene expression signature predicts poor patient outcome: Are cancer stem cells to blame?
por: Wicha, Max S
Publicado: (2012)

Chemokines and cellular plasticity of ovarian cancer stem cells
por: Zou, Weiping, et al.
Publicado: (2015)

The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse
por: Marchini, Cristina, et al.
Publicado: (2011)

Mammary stem cell number as a determinate of breast cancer risk
por: Ginestier, Christophe, et al.
Publicado: (2007)

Mammary stem cells, self-renewal pathways, and carcinogenesis
por: Liu, Suling, et al.
Publicado: (2005)

Adaptation of the AID system for stem cell and transgenic mouse research
por: Pryzhkova, Marina V., et al.
Publicado: (2020)

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice
por: Li, You-Jun, et al.
Publicado: (2015)

Comparative characterization of mesenchymal stem cells from eGFP transgenic and non-transgenic mice
por: Ripoll, Cynthia B, et al.
Publicado: (2009)

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
por: De Giovanni, Carla, et al.
Publicado: (2014)

Clinical Trial Design for Testing the Stem Cell Model for the Prevention and Treatment of Cancer
por: Reddy, Rishindra M., et al.
Publicado: (2011)

Enhancement of Transgene Expression by HDAC Inhibitors in Mouse Embryonic Stem Cells
por: Kim, Young-Eun, et al.
Publicado: (2013)

The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness
por: Ma, Yuxi, et al.
Publicado: (2021)

Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors
por: Chen, Muhan, et al.
Publicado: (2009)

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
por: Li, Qiao, et al.
Publicado: (2014)

Transgenic mouse model of cutaneous adnexal tumors
por: Kito, Yusuke, et al.
Publicado: (2014)

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
por: Lee, Eunmi, et al.
Publicado: (2019)

Generation and characterization of an inducible transgenic model for studying mouse esophageal biology
por: Roth, Sabrina, et al.
Publicado: (2012)

Characterization of a transgenic mouse model of chronic conditional platelet depletion
por: Wuescher, Leah M., et al.
Publicado: (2019)

Mapping Transgene Insertion Sites Reveals Complex Interactions Between Mouse Transgenes and Neighboring Endogenous Genes
por: Laboulaye, Mallory A., et al.
Publicado: (2018)

The ontogeny of myometrial stem cells in OCT4-GFP transgenic mouse model
por: Brakta, Soumia, et al.
Publicado: (2018)

Biological and clinical significance of cancer stem cell plasticity
por: Zhu, Yongyou, et al.
Publicado: (2014)

Characterization of Gastric and Neuronal Histaminergic Populations Using a Transgenic Mouse Model
por: Walker, Angela K., et al.
Publicado: (2013)

Characterization of a Trpc6 Transgenic Mouse Associated with Early Onset FSGS
por: Canales, Cesar P., et al.
Publicado: (2014)

Generation and Characterization of a Transgenic Mouse That Specifically Expresses the Cre Recombinase in Spermatids
por: Gobé, Clara, et al.
Publicado: (2023)

Breast tumors: of mice and women
por: McDermott, Sean P, et al.
Publicado: (2010)

Carcinogenesis in transgenic mouse models.
por: Lyon, T
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_vr6j5lbvq59th6quj9iqgmdbng